1 Introduction The conversion of simple, aromatic heterocycles into complex 3D chiral molecules by reductive dearomatization is a highly efficient strategy for the synthesis of pharmaceutical intermediates and other compounds [1]. Chemical dearomatization strategies have improved regarding control of regio- and stereoselectivity; however, challenges still remain with respect to safe operation and economic viability [-–7].